Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
TGAN Stock Summary
Top 10 Correlated ETFs
TGAN
In the News

Transphorm to Present at Upcoming December Investor Conference
GOLETA, Calif.--( BUSINESS WIRE )--Transphorm, Inc. (NASDAQ: TGAN)—a pioneer in and global supplier of high-reliability, high-performance gallium nitride (GaN) power conversion products, announced today President & COO, Primit Parikh, Ph.D., will present at the Oppenheimer 5G Summit: The Revolution Continues, which is being held virtually on December 13, 2022. Management is scheduled to host a live fireside chat and will be available throughout the day to meet with participating investors.

Transphorm, Inc. (TGAN) Q2 2023 Earnings Call Transcript
Transphorm, Inc. (NASDAQ:TGAN ) Q2 2023 Results Conference Call November 9, 2022 5:00 PM ET Company Participants Jack Perkins - KCSA Strategic Communications Mario Rivas - CEO Primit Parikh - Co-Founder, President and COO Cameron McAulay - CFO Conference Call Participants David Williams - Benchmark Company Craig Ellis - B. Riley Ananda Baruah - Loop Capital Sam Peterman - Craig-Hallum Orin Hirschman - AIGH Partners Operator Good day, and thank you for standing by.

Transphorm, Inc. (TGAN) Reports Q2 Loss, Tops Revenue Estimates
Transphorm, Inc. (TGAN) delivered earnings and revenue surprises of 18.18% and 1.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Transphorm to Announce Fiscal 2023 Second Quarter Financial Results and Host Business Update Call on November 9th at 5:00pm ET
GOLETA, Calif.

Transphorm to Present at Upcoming September Investor Conferences
GOLETA, Calif.--(BUSINESS WIRE)--Transphorm, Inc. (NASDAQ: TGAN), a pioneer in and global supplier of high-reliability, high-performance gallium nitride (GaN) power conversion products, announced today President & COO, Primit Parikh, Ph.D., and CFO, Cameron McAulay, will present at the H.C. Wainwright 24th Annual Global Conference and the Sequire Semiconductor Conference, on September 12th, and September 15th, respectively. H.C. Wainwright 24th Annual Global Investment Conference Presentati

Transphorm, Inc. (TGAN) Management on Q1 2023 Results - Earnings Call Transcript
Transphorm, Inc. (NASDAQ:TGAN ) Q1 2023 Earnings Conference Call August 15, 2022 5:00 PM ET Company Participants Jack Perkins - KCSA Strategic Communications Primit Parikh - Co-Founder, President and Chief Operating Officer Cameron McAulay - Chief Financial Officer Conference Call Participants Ananda Baruah - Loop Capital Craig Ellis - B. Riley Securities David Williams - Benchmark Company Richard Shannon - Craig-Hallum Capital Group Operator Good day everyone.

Transphorm, Inc. (TGAN) Reports Q1 Loss, Misses Revenue Estimates
Transphorm, Inc. (TGAN) delivered earnings and revenue surprises of -14.29% and 0.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Transphorm to Announce Fiscal 2023 First Quarter Financial Results and Host Business Update Call on August 15th at 5:00pm ET
GOLETA, Calif.--(BUSINESS WIRE)--Transphorm, Inc. (NASDAQ: TGAN)—a pioneer in and global supplier of high-reliability, high-performance gallium nitride (GaN) power conversion products, announced today it will host a conference call and webcast on Monday, August 15, 2022 at 5:00 p.m. ET to discuss the Company's financial results for the 2023 fiscal first quarter. Conference Call and Webcast Information Event: Transphorm Fiscal 2023 First Quarter Full Year Financial Results Date: Monday, August 1

Transphorm: Turning Technology Into Revenue
Transphorm, Inc. is a leader in the development of GaN semiconductor technology, particularly for higher power applications. It has a second line of business in GaN epitaxial wafer fabrication.

Transphorm, Inc. (TGAN) CEO Mario Rivas on Q4 2022 Results - Earnings Call Transcript
Transphorm, Inc. (NASDAQ:TGAN ) Q4 2022 Earnings Conference Call May 24, 2022 5:00 PM ET Company Participants Mario Rivas - CEO & Director Primit Parikh - Co-Founder & COO Cameron McAulay - CFO Conference Call Participants David Williams - The Benchmark Company Ananda Baruah - Loop Capital Markets Richard Shannon - Craig-Hallum Orin Hirschman - AIGH Investment Partners Operator Good afternoon. My name is Savannah, and I will be your conference operator.
TGAN Financial details
TGAN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2019-12-31 | 2020-12-31 | 2022-03-31 |
---|---|---|---|---|
Revenue per share | 0.34 | 0.32 | 0.52 | |
Net income per share | -0.43 | -0.51 | -0.22 | |
Operating cash flow per share | -0.35 | -0.4 | -0.43 | |
Free cash flow per share | -0.36 | -0.4 | -0.44 | |
Cash per share | 0.08 | 0.42 | 0.73 | |
Book value per share | -3.48 | -0.57 | 0.68 | |
Tangible book value per share | -3.55 | -0.63 | 0.64 | |
Share holders equity per share | -3.48 | -0.57 | 0.68 | |
Interest debt per share | 1.21 | 1.03 | 0.28 | |
Market cap | 175.68M | 144.06M | 325.62M | |
Enterprise value | 214.43M | 164.91M | 304.36M | |
P/E ratio | -11.49 | -8.04 | -31.81 | |
Price to sales ratio | 14.72 | 12.67 | 13.54 | |
POCF ratio | -14.29 | -10.21 | -16.5 | |
PFCF ratio | -14.06 | -10.16 | -16.02 | |
P/B Ratio | -1.44 | -7.26 | 10.38 | |
PTB ratio | -1.44 | -7.26 | 10.38 | |
EV to sales | 17.97 | 14.5 | 12.66 | |
Enterprise value over EBITDA | -16.11 | -10.11 | -35.39 | |
EV to operating cash flow | -17.45 | -11.68 | -15.42 | |
EV to free cash flow | -17.16 | -11.64 | -14.97 | |
Earnings yield | -0.09 | -0.12 | -0.03 | |
Free cash flow yield | -0.07 | -0.1 | -0.06 | |
Debt to equity | -1.08 | -2.12 | 0.55 | |
Debt to assets | 12.91 | 1.89 | 0.36 | |
Net debt to EBITDA | -2.91 | -1.28 | 2.47 | |
Current ratio | 0.26 | 0.68 | 8.48 | |
Interest coverage | -15.72 | -17.63 | -12.49 | |
Income quality | 0.8 | 0.79 | 1.93 | |
Dividend Yield | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.55 | 0.91 | 0.47 | |
Research and developement to revenue | 0.68 | 0.49 | 0.28 | |
Intangibles to total assets | 0.26 | 0.11 | 0.04 | |
Capex to operating cash flow | 0.02 | 0 | 0.03 | |
Capex to revenue | -0.02 | -0.01 | -0.02 | |
Capex to depreciation | -0.17 | -0.07 | -0.71 | |
Stock based compensation to revenue | 0.05 | 0.13 | 0.11 | |
Graham number | 5.84 | 2.55 | 1.85 | |
ROIC | -5.6 | 1.3 | 0.45 | |
Return on tangible assets | -2 | -0.9 | -0.22 | |
Graham Net | -3.66 | -0.74 | 0.46 | |
Working capital | -15.33M | -8.46M | 39.51M | |
Tangible asset value | -124.89M | -22.24M | 29.56M | |
Net current asset value | -127.16M | -23.86M | 27.51M | |
Invested capital | -0.34 | -1.79 | 0.39 | |
Average receivables | 0 | 776.5K | 0 | |
Average payables | 0 | 2.78M | 0 | |
Average inventory | 0 | 1.31M | 0 | |
Days sales outstanding | 21.68 | 27.09 | 38.82 | |
Days payables outstanding | 133.98 | 173.81 | 104.52 | |
Days of inventory on hand | 55.66 | 88.87 | 184.39 | |
Receivables turnover | 16.83 | 13.47 | 9.4 | |
Payables turnover | 2.72 | 2.1 | 3.49 | |
Inventory turnover | 6.56 | 4.11 | 1.98 | |
ROE | 0.13 | 0.9 | -0.33 | |
Capex per share | -0.01 | 0 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.27 | 0.09 | 0.1 | 0.06 | 0.08 | |
Net income per share | 0.15 | -0.08 | -0.1 | -0.11 | -0.18 | |
Operating cash flow per share | -0.09 | -0.11 | -0.09 | -0.09 | -0.24 | |
Free cash flow per share | -0.09 | -0.11 | -0.11 | -0.14 | -0.28 | |
Cash per share | 0.05 | 0.82 | 0.8 | 0.59 | 0.41 | |
Book value per share | -0.47 | 0.74 | 0.79 | 0.64 | 0.5 | |
Tangible book value per share | -0.52 | 0.7 | 0.76 | 0.62 | 0.47 | |
Share holders equity per share | -0.47 | 0.74 | 0.79 | 0.64 | 0.5 | |
Interest debt per share | 0.68 | 0.26 | 0.29 | 0.27 | 0.27 | |
Market cap | 186.21M | 393.18M | 203.24M | 284.8M | 308.66M | |
Enterprise value | 212M | 365.08M | 176.09M | 266.64M | 300.72M | |
P/E ratio | 7.78 | -23.61 | -9.49 | -11.88 | -7.38 | |
Price to sales ratio | 16.47 | 85.4 | 39.42 | 77.6 | 68.7 | |
POCF ratio | -48.63 | -74.21 | -41.37 | -58.12 | -22.56 | |
PFCF ratio | -47.84 | -70.48 | -36.06 | -34.72 | -19.28 | |
P/B Ratio | -9.53 | 10.86 | 4.85 | 7.84 | 10.95 | |
PTB ratio | -9.53 | 10.86 | 4.85 | 7.84 | 10.95 | |
EV to sales | 18.76 | 79.3 | 34.15 | 72.65 | 66.93 | |
Enterprise value over EBITDA | 33.08 | -97.07 | -36.72 | -49.05 | -31.63 | |
EV to operating cash flow | -55.37 | -68.91 | -35.84 | -54.42 | -21.98 | |
EV to free cash flow | -54.47 | -65.44 | -31.24 | -32.5 | -18.78 | |
Earnings yield | 0.03 | -0.01 | -0.03 | -0.02 | -0.03 | |
Free cash flow yield | -0.02 | -0.01 | -0.03 | -0.03 | -0.05 | |
Debt to equity | -1.73 | 0.51 | 0.52 | 0.59 | 0.75 | |
Debt to assets | 2.36 | 0.34 | 0.34 | 0.37 | 0.43 | |
Net debt to EBITDA | 4.03 | 7.47 | 5.66 | 3.34 | 0.84 | |
Current ratio | 0.47 | 7.65 | 2.96 | 2.48 | 1.98 | |
Interest coverage | 17.88 | -25.5 | -27.66 | -29.9 | -53.79 | |
Income quality | -0.64 | 1.27 | 0.92 | 0.82 | 0.87 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.24 | 0.62 | 0.64 | 0.83 | 0.77 | |
Research and developement to revenue | 0.14 | 0.35 | 0.34 | 0.5 | 0.52 | |
Intangibles to total assets | 0.14 | 0.04 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | 0.02 | 0.05 | 0.15 | 0.67 | 0.17 | |
Capex to revenue | -0.01 | -0.06 | -0.14 | -0.9 | -0.52 | |
Capex to depreciation | -0.3 | -1.3 | -1.92 | -8.81 | -3.03 | |
Stock based compensation to revenue | 0.05 | 0.18 | 0.11 | 0.17 | 0.38 | |
Graham number | 1.24 | 1.19 | 1.33 | 1.24 | 1.44 | |
ROIC | 0.62 | 0.15 | 0.19 | 0.41 | 9.26 | |
Return on tangible assets | 0.49 | -0.08 | -0.09 | -0.11 | -0.22 | |
Graham Net | -0.69 | 0.54 | 0.5 | 0.31 | 0.15 | |
Working capital | -11.71M | 44.04M | 37M | 27.85M | 18.01M | |
Tangible asset value | -21.6M | 34.28M | 40.34M | 34.88M | 26.69M | |
Net current asset value | -23.71M | 32.04M | 34.06M | 25.04M | 15.34M | |
Invested capital | -1.42 | 0.34 | 0.37 | 0.42 | 0.54 | |
Average receivables | 1.92M | 2.04M | 2.41M | 2.41M | 2.66M | |
Average payables | 3.9M | 4.4M | 3.91M | 4.58M | 4.25M | |
Average inventory | 3.85M | 5.37M | 4.59M | 7.96M | 8.22M | |
Days sales outstanding | 12.62 | 48.66 | 55.91 | 39.65 | 74.2 | |
Days payables outstanding | 162.68 | 108.62 | 103.87 | 125.09 | 50.47 | |
Days of inventory on hand | 191.9 | 136.22 | 154.73 | 249.67 | 93.95 | |
Receivables turnover | 7.13 | 1.85 | 1.61 | 2.27 | 1.21 | |
Payables turnover | 0.55 | 0.83 | 0.87 | 0.72 | 1.78 | |
Inventory turnover | 0.47 | 0.66 | 0.58 | 0.36 | 0.96 | |
ROE | -0.31 | -0.11 | -0.13 | -0.16 | -0.37 | |
Capex per share | 0 | -0.01 | -0.01 | -0.06 | -0.04 |
TGAN Frequently Asked Questions
What is Transphorm, Inc. stock symbol ?
Transphorm, Inc. is a US stock , located in Goleta of Ca and trading under the symbol TGAN
What is Transphorm, Inc. stock quote today ?
Transphorm, Inc. stock price is $4.11 today.
Is Transphorm, Inc. stock public?
Yes, Transphorm, Inc. is a publicly traded company.